FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012206449> ?p ?o ?g. }

• W2012206449 endingPage "2144" @default.
• W2012206449 startingPage "2132" @default.
• W2012206449 abstract "Tumor-associated inflammation mediates the development of a systemic immunosuppressive milieu that is a major obstacle to effective treatment of cancer. Inflammation has been shown to promote the systemic expansion of immature myeloid cells which have been shown to exert immunosuppressive activity in laboratory models of cancer as well as cancer patients. Consequentially, significant effort is underway toward the development of therapies that decrease tumor-associated inflammation and immunosuppressive cells. The current study demonstrated that a previously described deep tissue imaging modality, which utilized indocyanine green-loaded calcium phosphosilicate nanoparticles (ICG-CPSNPs), could be utilized as an immunoregulatory agent. The theranostic application of ICG-CPSNPs as photosensitizers for photodynamic therapy was shown to block tumor growth in murine models of breast cancer, pancreatic cancer, and metastatic osteosarcoma by decreasing inflammation-expanded immature myeloid cells. Therefore, this therapeutic modality was termed PhotoImmunoNanoTherapy. As phosphorylated sphingolipid metabolites have been shown to have immunomodulatory roles, it was hypothesized that the reduction of immature myeloid cells by PhotoImmunoNanoTherapy was dependent upon bioactive sphingolipids. Mechanistically, PhotoImmunoNanoTherapy induced a sphingosine kinase 2-dependent increase in sphingosine-1-phosphate and dihydrosphingosine-1-phosphate. Furthermore, dihydrosphingosine-1-phosphate was shown to selectively abrogate myeloid lineage cells while concomitantly allowing the expansion of lymphocytes that exerted an antitumor effect. Collectively, these findings revealed that PhotoImmunoNanoTherapy, utilizing the novel nontoxic theranostic agent ICG-CPSNP, can decrease tumor-associated inflammation and immature myeloid cells in a sphingosine kinase 2-dependent manner. These findings further defined a novel myeloid regulatory role for dihydrosphingosine-1-phosphate. PhotoImmunoNanoTherapy holds the potential to be a revolutionary treatment for cancers with inflammatory and immunosuppressive phenotypes." @default.
• W2012206449 created "2016-06-24" @default.
• W2012206449 creator A5012506055 @default.
• W2012206449 creator A5013467765 @default.
• W2012206449 creator A5021258109 @default.
• W2012206449 creator A5025034153 @default.
• W2012206449 creator A5027382068 @default.
• W2012206449 creator A5032107158 @default.
• W2012206449 creator A5034128364 @default.
• W2012206449 creator A5034379540 @default.
• W2012206449 creator A5040990076 @default.
• W2012206449 creator A5052749373 @default.
• W2012206449 creator A5059706312 @default.
• W2012206449 creator A5079588934 @default.
• W2012206449 creator A5088958002 @default.
• W2012206449 creator A5091844856 @default.
• W2012206449 date "2013-02-14" @default.
• W2012206449 modified "2023-09-26" @default.
• W2012206449 title "PhotoImmunoNanoTherapy Reveals an Anticancer Role for Sphingosine Kinase 2 and Dihydrosphingosine-1-Phosphate" @default.
• W2012206449 cites W1925817305 @default.
• W2012206449 cites W1966153114 @default.
• W2012206449 cites W1966452335 @default.
• W2012206449 cites W1967802627 @default.
• W2012206449 cites W1970053010 @default.
• W2012206449 cites W1970811571 @default.
• W2012206449 cites W1993340690 @default.
• W2012206449 cites W1996605319 @default.
• W2012206449 cites W1999422072 @default.
• W2012206449 cites W2000673878 @default.
• W2012206449 cites W2004150448 @default.
• W2012206449 cites W2018548034 @default.
• W2012206449 cites W2023611912 @default.
• W2012206449 cites W2035954535 @default.
• W2012206449 cites W2042642780 @default.
• W2012206449 cites W2044789744 @default.
• W2012206449 cites W2049277998 @default.
• W2012206449 cites W2052872089 @default.
• W2012206449 cites W2055399590 @default.
• W2012206449 cites W2064296350 @default.
• W2012206449 cites W2068920186 @default.
• W2012206449 cites W2074616725 @default.
• W2012206449 cites W2085063849 @default.
• W2012206449 cites W2087258337 @default.
• W2012206449 cites W2090937723 @default.
• W2012206449 cites W2092931587 @default.
• W2012206449 cites W2119536609 @default.
• W2012206449 cites W2122359067 @default.
• W2012206449 cites W2125144175 @default.
• W2012206449 cites W2128957395 @default.
• W2012206449 cites W2138940299 @default.
• W2012206449 cites W2146595615 @default.
• W2012206449 cites W2157269800 @default.
• W2012206449 cites W2170123390 @default.
• W2012206449 cites W2313365551 @default.
• W2012206449 cites W2322174751 @default.
• W2012206449 cites W94821320 @default.
• W2012206449 cites W2028912433 @default.
• W2012206449 doi "https://doi.org/10.1021/nn304862b" @default.
• W2012206449 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3757127" @default.
• W2012206449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23373542" @default.
• W2012206449 hasPublicationYear "2013" @default.
• W2012206449 type Work @default.
• W2012206449 sameAs 2012206449 @default.
• W2012206449 citedByCount "27" @default.
• W2012206449 countsByYear W20122064492013 @default.
• W2012206449 countsByYear W20122064492014 @default.
• W2012206449 countsByYear W20122064492015 @default.
• W2012206449 countsByYear W20122064492017 @default.
• W2012206449 countsByYear W20122064492018 @default.
• W2012206449 countsByYear W20122064492019 @default.
• W2012206449 countsByYear W20122064492020 @default.
• W2012206449 countsByYear W20122064492021 @default.
• W2012206449 countsByYear W20122064492023 @default.
• W2012206449 crossrefType "journal-article" @default.
• W2012206449 hasAuthorship W2012206449A5012506055 @default.
• W2012206449 hasAuthorship W2012206449A5013467765 @default.
• W2012206449 hasAuthorship W2012206449A5021258109 @default.
• W2012206449 hasAuthorship W2012206449A5025034153 @default.
• W2012206449 hasAuthorship W2012206449A5027382068 @default.
• W2012206449 hasAuthorship W2012206449A5032107158 @default.
• W2012206449 hasAuthorship W2012206449A5034128364 @default.
• W2012206449 hasAuthorship W2012206449A5034379540 @default.
• W2012206449 hasAuthorship W2012206449A5040990076 @default.
• W2012206449 hasAuthorship W2012206449A5052749373 @default.
• W2012206449 hasAuthorship W2012206449A5059706312 @default.
• W2012206449 hasAuthorship W2012206449A5079588934 @default.
• W2012206449 hasAuthorship W2012206449A5088958002 @default.
• W2012206449 hasAuthorship W2012206449A5091844856 @default.
• W2012206449 hasBestOaLocation W20122064492 @default.
• W2012206449 hasConcept C121608353 @default.
• W2012206449 hasConcept C126322002 @default.
• W2012206449 hasConcept C170493617 @default.
• W2012206449 hasConcept C184235292 @default.
• W2012206449 hasConcept C185592680 @default.
• W2012206449 hasConcept C203014093 @default.
• W2012206449 hasConcept C2776596873 @default.
• W2012206449 hasConcept C2776914184 @default.
• W2012206449 hasConcept C2777550365 @default.

• next